% 28.0% % 28.5% % 27.0% % 20.1% % ,831

Similar documents
産業21-81号.72.indd

Contents

monndai .ai

untitled

.T.C.Y._.E..

退職互助だより_cs6.indd

REPORT



18“ƒ-7/18 (Page Ł\1)

2016 GOP 一般ランキング

ヘルスケアレポートvol.17

ヘルスケアレポートvol.16

TAIHO_E&S

名大_医学部保健学科年報第8巻/巻頭

untitled


FBhyou1_140324

DocuPrint C5450 ユーザーズガイド

19“ƒ-11/05 (Page Ł\1)

M-E20B_OWNER'S MANUAL.pdf

01 Asahi Breweries Group CSR Report 2004 (Data Book)

untitled


sociologos_syohyou04_han3.indd

図書館だより№79

看護通信85_S.indd


2013_autumn.indb

1

3131_2014_02.pdf

C O N T E N T S Annual Report

18年度石見美術館年報最終.indd

untitled

CSR Report

advantest_cr.indd

life_6.pdf

CSRレポート2930

No2 MAR.ren

™¼fi⁄10„”Šp


™¼fi⁄PDFŠp

™¼fi⁄CTPŠp

™¼fi⁄CTPŠp

腎不全-第17回-表紙付.indd


平成15年度

D-Report_2015春号0421_mihon

02



立命館


_2008_sep.ren

x......


_2008JUL.ren


産業21-77号.indd

00陦ィ邏

PUBLICITY REPORT

ペットブック_表紙&扉_Fin

11“ƒ…„…C…A…E…g10/16* (Page 1)



aeronca_537_color.indd

19

11

01_ i...V.j

2000年11月21日

A E A A A A E A E EAE EAE EA AE E AE E A AE EA AE EA AE EA AE EA AE EAE EAE EAE EAE E AE E A AE EA AE EAE E AE EA AE E AE E A AE E E A AE E E A AE EA

JICE REPORT 45

CONTENTS

...A

4% P % 11.1%1, % %1, %1, % 3.5%1, % %1, % Santen Ph

起業本-入稿.indd


_04特集.indd

_Œ{Ł¶†^No3 MAY.ren

健康文化44

環境報告書2015.indd


3 4


1

untitled

untitled

表1-4.ai

2010J_web_cover

P R O F I L E

2

02 CSR REPORT 09

JPドメイン名レジストリレポート 2013

01

‡ç‡¢‡Ó‡Ü‡Á‡Õ04-08„”


RESPONSIBLE CARE REPORT 2004


SB/2002/P1-66/8.14b (Page 1)

untitled

Transcription:

60,127 61,002 60,342 51,369 52,016 51,470 62,030 62,666 53,167 53,807 57,477 56,526 56,991 66,822 65,979 66,568 64,349 60,313 55,168 69,061 66,850 58,686 IMS HEALTH, World Review 2002 11

21.8 29.5% 28.0% 23.5 26.1% 28.5% 24.4 25.8 28.5 27.0 24.5% 27.0% 29.1 29.8 30.9 23.3% 20.1% 30.4 19.6% 5.2 5.1 5.3 5.4 5.7 5.7 5.7 5.5 6.0 5.9 6,831 10.2% 6,874 5.6% 2.4% 7,176 3.0% 1.3% 7,236 3.9% 1.7% 7,119 3.4% 1.5% 6,891 1.55% 0.4% 13,654 5.8% 2.0% 12,881 18.6% 6.1% 16,100 4.9% 1.5%BL 13,471 16.6% 5.1% 14,946 6.0% 1.9% 15,166 5.1% 1.5% 13,636 10.2% 2.9% 13,713 2.7% 0.65% 13,352 9.2% 2.7% 13,573 8.1% 2.4% R15) 13,375 6.6% 2.0%R13) 12,869 6.8% 2.6%R11) 11,974 4.4% 1.27%R10) 11,692 9.7% 2.7%R5 11,287 7.0% 1.6% 11,191 6.3% 1.3% 12

IMS HEALTH,PharmaPrognosis IMS WORLD REVIEW 13

19.8% 20.0%20.3% 16.9% 18.6% 20.0% 21.7% 24.0% 20.5% 25.5% 25.6% 102 69 42 28 23 14 8 12 11 5 4 6 6 9 10 11 11 18 20 7 7 66 14

19751998 810 584 15

RED BOOK 1998 Arzneiverordnungs-Report 1998 16

17

12 1 63 101 12 70 103 3 74 104 18 14 367 18

19

-2392-2731 -2882-2836 -2758-2477 -2192 20

-25 25-7 -65-36 -13 0 143 244 420 666 474 21

22

23

18.0 61.7 33.5 39.3 48.0 71.8 98.2 39.6 35.5 29.1 17.9 39.4 36.3 24

B C D F EA 1 963,480 4.4% 683,323 280,157 30.5% 29.1% 1,005,060 4.3% 656,346-3.9% 348,714 24.5% 34.7% 2 545,072-7.6% 447,631 97,441-12.1% 17.9% 548,893 0.7% 431,293-3.6% 117,600 20.7% 21.4% 3 457,913 5.6% 277,674 180,239 4.7% 39.4% 481,327 5.1% 289,605 4.3% 191,722 6.4% 39.8% 4 361,712 19.6% 229,632 132,080 46.2% 36.5% 431,673 19.3% 232,090 1.1% 199,583 51.1% 46.2% 5 297,516 2.9% 189,436 108,080 5.8% 36.3% 341,356 14.7% 190,807 0.7% 150,549 39.3% 44.1% 6 317,072 5.5% 255,745 61,327 25.8% 19.3% 332,753 4.9% 259,528 1.5% 73,225 19.4% 22.0% 7 181,412-8.9% 152,119 29,293 0.6% 16.1% 228,983 26.2% 183,314 20.5% 45,669 55.9% 19.9% 8 203,005 3.8% 179,199 23,806 9.6% 11.7% 211,705 4.3% 182,593 1.9% 29,112 22.3% 13.8% 9 194,027 4.8% 177,650 16,377-11.2% 8.4% 189,671-2.2% 170,664-3.9% 19,007 16.1% 10.0% 10 176,049 2.8% 117,884 58,165 5.3% 33.0% 187,082 6.3% 120,145 1.9% 66,937 15.1% 35.8% 11 130,728 2.7% 129,006 1,722 18.8% 1.3% 133,353 2.0% 131,774 2.1% 1,579-8.3% 1.2% 12 88,448 5.8% 82,753 5,695 18.9% 6.4% 88,966 0.6% 80,648-2.5% 8,318 46.1% 9.3% 13 55,832 5.8% 47,186 8,646 25.3% 15.5% 62,395 11.8% 50,268 6.5% 12,127 40.3% 19.4% 14 58,936 3.3% 58,670 266-52.5% 0.5% 59,929 1.7% 59,584 1.6% 345 29.7% 0.6% 4,031,202 3,027,908 1,003, 294-24.9% 4,303,146 6.7% 3,038,659 0.4% 1,264,487 26.0% 29.4% 51.1% 39.3% 55.9% 40.3% 24.5% 20.7% 26.2% 19.3% 14.7% 20.5% 22.3% 19.4% 16.1% 15.1% 6.4% 11.8% 4.9% 4.3% 6.3% 5.1% 4.3% 0.7% 1.1% 0.7% 1.5% 1.9% -2.2% 1.9% 6.5% -3.9% 4.3% -3.6% -3.9% 25

25,518 13.1% 24,973 11.5% 21,351 5.6% 16,057 4.2% 15,659 9.8% 15,300 6.3% 14,851 17.3% 13,519 15.7% 11,970 10.6% 10,940 9.6% 10,856 6.6% 10,200 6.7% 9,000 8,369 0.3% 6,277 54.5% 5,850 16.9% 5,616 14.6% 5,076-6.7% 4,665 10.4% 4,149 7.9% 4,016 10.6% 3,787 7.0% 3,220 2.3% 3,092 21.3% 2,911 8.2% 2,820 14.2% 2,807 4.4% 2,666 14.9% 2,651 13.6% 2,306 6.5% 2,270 19.9% 2,072 25.8% 265,814 11.7% 26

Scrip's Year Book World Ranking Scrip's 1999 Pharmaceutical Company League Tables 27

1517 23 35 37 12 406,753 235 1:1,731 147 1:1.6 1:2,767 36 1:11,299 64 1:1.3 1:6,356 83 1:1.8 1:4,901 28

6.06 5.54 5.57 6.73 6.95 7.05 6.83 6.63 6.04 6.31 6.49 6.87 8.03 8.11 8.06 8.07 8.07 8.60 29

9,635 2,261 23.5 1,469 15.2 898.5 5,451 878 16.1 425 7.8 787.6 4,579 21.4 8.8 545.0 4,127 5.8 3.1 292.6 3,617 16.3 6.4 496.1 3,171 20.1 9.0 399.9 2,975 11.3 6.9 520.1 2,030 14.9 7.6 411.9 4,448 778 17.5 413 9.3 544 46,204 11,246 24.3 7,809 16.9 2,683 33,853 6,618 19.5 4,265 12.6 5,077 33,355 7,580 22.7 5,495 16.5 3,349 20,852 6,271 30.1 5,393 25.9 2,220 20,769 1,572 7.6 821 4.0 3,151 15,182 2,878 19.0 2,714 17.9 1,932 12,434 4,417 35.5 3,500 28.2 2,311 11,235 3,649 32.5 2,774 24.7 1,526 24,236 5,529 22.8 4,096 16.9 2,781 33,405 3,545 10.6 1,959 5.9 2,581 30,942 8,602 27.8 6,327 20.4 4,296 25,448 5,603 22.0 5,124 20.1 3,310 24,057 4,087 17.0 1,215 5.0 3,550 20,946 4,588 21.9 2,905 13.9 3,312 20,378 5,068 24.9 6,146 30.2 2,807 6,674 863 12.9 409 6.1 1,044 6,432 1,701 26.4 1,073 16.7 1,019 21,035 4,257 20.2 3,145 15.0 2,740 30

603 10.8 9.3 11.2 11.2 11.4 10.7 10.4 9.8 692 798 841 904 11.7 10.2 1100 12.0 11.8 11.0 1272 12.6 10.6 10.7 1411 1565 263 283 297 302 321 334 346 369 386 14.3 12.2 1900 11.4 11.1 10.7 2310 433 488 12.9 31

32

33

34

35

36

29.1% 160 115 10 4 95 71 54 63 52 43 18.3% 23 46.0% 58 35.7% 45 43.2% 70 36.4% 59 37 20.4% 33

38

55,000 62,000 17,000 9,500 21,500 6,000 2,000 4,000 240,908 756,710 305,153 117,417 171,807 4.4 12.2 18.0 12.4 8.0 38.8 74.1 15.5 8.4 14.2 0.71 1.20 0.91 0.88 0.66 39